🇨🇦 long acting injectable risperidone, High Dose Group in Canada

long acting injectable risperidone, High Dose Group (long acting injectable risperidone, High Dose Group) regulatory status in Canada.

Marketing authorisation

long acting injectable risperidone, High Dose Group in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is long acting injectable risperidone, High Dose Group approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for long acting injectable risperidone, High Dose Group in Canada?

Northwestern University is the originator. The local marketing authorisation holder may differ — check the official source linked above.